EW-7197
EW-7197
- CAS:
- 1352608-82-2
- MF:
- C22H18FN7
- MW:
- 399.42
Suppliers by country/region
Company Type
Properties
- Melting point:
- >85oC (dec.)
- Density
- 1.40±0.1 g/cm3(Predicted)
- storage temp.
- Refrigerator
- solubility
- DMSO (Slightly), Methanol (Slightly)
- pka
- 8.51±0.10(Predicted)
- form
- Solid
- color
- Pale Yellow to Light Yellow
Safety Information
- Symbol(GHS)
GHS07
- Signal word
- Warning
- Hazard statements
- H315-H319-H335
- Precautionary statements
- P261-P305+P351+P338
Use
EW-7197 is a novel ALK-5 kinase inhibitor as well as TGF- Type I Receptor Kinase Inhibitor. Study has shown that it can potently inhibit the breast to lung metastasis. Mice study has demonstrated that EW-7197 inhibited Smad/TGF signaling, cell migration, invasion, and lung metastasis in MMTV/c-Neu mice and 4T1 orthotopic-grafted mice. EW-7197 also inhibited the epithelial-to-mesenchymal transition (EMT) in both TGF-treated breast cancer cells and 4T1 orthotopic-grafted mice. Furthermore, EW-7197 enhanced cytotoxic T lymphocyte activity in 4T1 orthotopic-grafted mice and increased the survival time of 4T1-Luc and 4T1 breast tumor-bearing mice. It can also inhibit hepatic, renal, and pulmonary fibrosis by blocking TGF-/Smad and ROS signaling. Therefore, it is a potential antitumor reagent.
1 India supplier list of "EW-7197"